In May 2016, the U.S. Food and Drug Administration (“FDA”) issued a formal advisory mandating labeling changes for antibacterial drugs called fluoroquinolones, including an updated boxed warning, stating that the serious side effects associated with fluoroquinolones outweigh the benefits for patients with sinusitis, bronchitis and uncomplicated urinary tract infections who have any other treatment options. The FDA re-emphasized those warnings in a further Alert on July 26, 2016, noting that the risk of serious Levaquin and other fluoroquinolone serious side effects generally outweighs the benefits to patients.
Information for Current Patients Injured by Fluoroquinolone Antibiotic Drugs
While the FDA’s alert and mandated changes will surely help patients not yet treated with Fluoroquinolones, existing patients with Fluoroquinolone-related injuries are urged to contact a personal injury lawyer to discuss their rights and potential lawsuits for injuries caused by these dangerous but widely-prescribed drugs.
Contact Lieff Cabraser
Lieff Cabraser’s personal injury attorneys have been leaders in some of the most important personal injury lawsuits in the U.S. involving dangerous, recalled, or mislabeled and mis-marketed prescription drugs. We welcome the chance to talk to you about your possible Fluoroquinolone antibiotic drug-related injuries. Please use the form below or call us toll-free at 1 800 541-7358 for a free, no-obligation review of your case.
Food & Drug Administration Warnings on Levaquin and other Fluoroquinolones
The FDA is alerting patients that commonly observed Levofloxacin (Levaquin) and Ciprofloxacin (Cipro) side effects like aortic aneurysm and aortic dissection are serious and prevalent enough that patients are cautioned to avoid fluoroquinolones absent strong medical evidence that their use is worth the elevated risk. The Agency cautions patients taking Levaquin and similar drugs to contact their health care professionals immediately if they experience any serious fluoroquinolone side effects.
The greater list of dangerous fluoroquinolone antibiotic medications includes:
- Ciprofloxacin (Cipro)
- Gemifloxacin (Factive)
- Levofloxacin (Levaquin)
- Moxifloxacin (Avelox)
- Norfloxacin (Noroxin)
- Ofloxacin (Floxin)
The FDA is also requiring label changes for all systemic fluoroquinolone antibacterial drugs to reflect the alerts relating to updated and expanded safety warnings on this class of antibiotic drugs.